Prokaryotic and eukaryotic transcription with their clinical applicationsrohini sane
A comprehensive presentation on Prokaryotic and Eukaryotic DNA transcription with their clinical applications for Medical, dental, Pharma & Biotechnology students to facilitate self- study.
Levels of organisation of DNA explains how 2 meters long DNA is compacted into chromatin. Useful self-assessment questions are given in the slides. If you want to know the answer, you can ask in comments.
Prokaryotic and eukaryotic transcription with their clinical applicationsrohini sane
A comprehensive presentation on Prokaryotic and Eukaryotic DNA transcription with their clinical applications for Medical, dental, Pharma & Biotechnology students to facilitate self- study.
Levels of organisation of DNA explains how 2 meters long DNA is compacted into chromatin. Useful self-assessment questions are given in the slides. If you want to know the answer, you can ask in comments.
Protein synthesis is the process whereby biological cells generate new proteins. Translation, the assembly of amino acids by ribosomes, is an essential part of the biosynthetic pathway, along with generation of messenger RNA (mRNA), aminoacylation of transfer RNA (tRNA), co-translational transport, and post-translational modification. Protein biosynthesis is strictly regulated at multiple steps. They are principally during transcription (phenomenon of RNA synthesis from DNA template) and translation (phenomenon of amino acid assembly from RNA). The cistron DNA is transcribed into the first of a series of RNA intermediates. The last version is used as a template in synthesis of a polypeptide chain. Protein will often be synthesized directly from genes by translating mRNA. A proprotein is an inactive protein containing one or more inhibitory peptides that can be activated when the inhibitory sequence is removed by proteolysis during post translational modification. A preprotein is a form that contains a signal sequence (an N-terminal signal peptide) that specifies its insertion into or through membranes, i.e., targets them for secretion. The signal peptide is cleaved off in the endoplasmic reticulum. Preproteins have both sequences (inhibitory and signal) still present. In protein synthesis, a succession of tRNA molecules charged with appropriate amino acids are brought together with an mRNA molecule and matched up by base-pairing through the anti-codons of the tRNA with successive codons of the mRNA. The amino acids are then linked together to extend the growing protein chain, and the tRNAs, no longer carrying amino acids, are released. This whole complex of processes is carried out by the ribosome, formed of two main chains of RNA, called ribosomal RNA (rRNA), and more than 50 different proteins. The ribosome latches onto the end of an mRNA molecule and moves along it, capturing loaded tRNA molecules and joining together their amino acids to form a new protein chain.
Transcription and synthesis of different RNAs
Processing of RNA transcript
Catalytic RNA
RNA splicing and Spliceosome
Transport of RNA through nuclear pore
Translation and polypeptide synthesis
Posttranslational modification
Protein trafficking and degradation
Antibiotics and inhibition of protein synthesis.
• Define transcription• Define translation• What are the 3 steps.pdfarihantelehyb
• Define transcription
• Define translation
• What are the 3 steps of translation?
• Define the “genetic dogma”
• What is the function of Transfer RNA?
• What is the function of RNA polymerase?
• What is the function of DNA polymerase?
• Define “splicing of RNA”
• What is an exon?
• What component of the cell does the translation?
• What molecule in the cell does transcription?
• What are the functions of: operon, promotor?
• What is the difference between inducible operon and repressible operon?
Solution
• Define transcription
Transcription is the process of making an RNA copy of a gene sequence. This copy, called a
messenger RNA (mRNA) molecule, leaves the cell nucleus and enters the cytoplasm, where it
directs the synthesis of the protein, which it encodes. Here is a more complete definition of
transcription.
• Define translation
Translation is the process of translating the sequence of a messenger RNA (mRNA) molecule to
a sequence of amino acids during protein synthesis. The genetic code describes the relationship
between the sequence of base pairs in a gene and the corresponding amino acid sequence that it
encodes. In the cell cytoplasm, the ribosome reads the sequence of the mRNA in groups of three
bases to assemble the protein. Here is a more complete definition of translation:
• What are the 3 steps of translation?
Step # 1. Initiation:
Initiation of translation in E .coli involves the small ribosome subunit, a mRNA molecule, a
specific charge initiator tRNA, GTP, Mg++ and number of proteinaceous initiation factors (IFs).
These are initially part of the small subunit and are required to enhance binding affinity of the
various translational components (Table 8.1). Unlike ribosomal proteins, IFs are released from
the ribosome once initiation is completed.
Step # 2. Elongation:
Once both subunits of the ribosome are assembled with the mRNA, binding site for two charged
tRNA molecules are formed. These are designated as the ‘P’ or peptidyl and the ‘A’ or
aminoacyl sites. The charged initiator tRNA binds to the P site, provided that the AUG triplet of
mRNA is in the corresponding position of the small subunit. The increase of the growing
polypeptide chain by one amino acid is called elongation.
Step # 3. Termination:
Termination of protein synthesis is carried out by triplet codes (UAG, UAA, UGA; stop codons)
present at site A. These codons do not specify an amino acid, nor do they call for a tRNA in the
A site. These codons are called stop codons, termination codons or nonsense codons. The
finished polypeptide is still attached to the terminal tRNA at the P site, and the A site is empty.
• Define the “genetic dogma”
A theory in genetics and molecular biology subject to several exceptions that genetic information
is coded in self-replicating DNA and undergoes unidirectional transfer to messenger RNAs in
transcription which act as templates for protein synthesis in translation
• What is the function of Transfer RNA?
The tRNA molecule, or tr.
Similar to Protein synthesis mechanism with reference of Translation and Transcription detail. (20)
Cellular Energy Transfer (Glycolysis and Krebs Cycle) and ATPmuhammad aleem ijaz
This presentation is all about Cellular Energy Transfer with reference to Glycolysis and Kreb Cycle with all their stages involved.
It also includes ATP production in the body, its importance, structure.
Also contains a comparison of energy production in Krebs and Glycolysis cycle.
This presentation is all about Renal System and it's Physiological Processes with complete description.
This is a presentation file for medical students of all disciplines.
This file is all about Skeletal Muscle contraction with reference to skeletal muscle Fibers, its structure, contraction, role of Ca++ in Contraction and types of Contraction.
This file is all about protein, its composition, functions, metabolism, importance in body, degradation and ways involved, as well as secretion with post transitional changes
This presentation file contains all about cell discovery, cell theory, organelles which are present within the cell and cell comparison between prokaryotic and Eukaryotic organisms.
This presentation is all about cell membrane transport. It contain different ways of transport of different substances in and out of cell membrane, along with active and passive mechanism.
This file is about cancer knowledge of initial level along with its cycle that shows how a cell change into cancerous one.
It's given cell cycle also help one in getting idea about what and how is it going on.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Protein synthesis mechanism with reference of Translation and Transcription detail.
1.
2. Protein
Synthesis
• The information content of DNA is in the form of specific sequences of
nucleotides along the DNA strands.
• The DNA inherited by an organism leads to specific traits by dictating
the synthesis of proteins.
• The process by which DNA directs protein synthesis, gene expression
includes two stages, called transcription and translation
• Cells are governed by a cellular chain of command:
• DNA → RNA → protein
Transcription
• Is the synthesis of RNA under the direction of DNA
• Produces messenger RNA (mRNA)
Translation
• Is the actual synthesis of a polypeptide, which occurs under the
direction of mRNA.
• Occurs on ribosomes.
3. The Central Dogma of
Life.
replication
Transcription and
Translation
In prokaryotes transcription
and translation occur
together
Prokaryotic cell. In a cell lacking a
nucleus, mRNA produced by
transcription is immediately
translated without additional
processing.
TRANSLATION
TRANSCRIPTION
DNA
mRNA
Ribosome
Polypeptide
4. Transcription and
TranslationIn a eukaryotic cell the nuclear envelope separates transcription from
translation.
Extensive RNA processing occurs in the nucleus.
Eukaryotic cell. The nucleus
provides a separate
compartment for
transcription. The original
RNA transcript, called pre-
mRNA, is processed in
various ways before leaving
the nucleus as mRNA.
TRANSCRIPTION
RNA PROCESSING
TRANSLATION
mRNA
DNA
Pre-mRNA
Polypeptide
Ribosome
Nuclear
envelope
5. Transcripti
on
Transcription is the DNA-directed synthesis
of RNA.
RNA synthesis Is catalyzed by RNA
polymerase, which pries the DNA strands
apart and hooks together the RNA
nucleotides.
Follows the same base-pairing rules as DNA,
except that in RNA, uracil substitutes for
thymine.
RN
ARNA is single stranded, not double stranded like DNA.
RNA is short, only 1 gene long, where DNA is very long and contains
many genes polygene RNA.
RNA uses the sugar ribose instead of deoxyribose in DNA
RNA uses the base uracil (U) instead of thymine (T) in DNA.
7. Promoter
Transcription unit
RNA polymerase
Start point
5′
3′
3′
5′
3′
5′
5′
3′
5′
3′
3′
5′
5′
3′
3′
5′
5′
5′
Rewound
RNA
RNA
transcript
3′
3′
Completed RNA transcript
Unwound
DNA
RNA
transcript
Template strand of DNA
DNA
1
Initiation. After RNA polymerase binds to
the promoter, the DNA strands unwind, and
the polymerase initiates RNA synthesis at the
start point on the template strand.
2
Elongation. The polymerase moves downstream,
unwinding the DNA and elongating the
RNA transcript 5′ → 3 ′. In the wake of
transcription, the DNA strands re-form a double helix.
3
Termination. Eventually, the RNA
transcript is released, and the
polymerase detaches from the DNA.
Synthesis of RNA Transcript
Stages:
8. Promoters signal the
initiation of RNA synthesis
Transcription factors help
eukaryotic RNA
polymerase recognize
promoter sequences
A crucial promoter DNA
sequence is called a TATA
box.
TRANSCRIPTION
RNA PROCESSING
TRANSLATION
DNA
Pre-mRNA
mRNA
Ribosome
Polypeptide
T A T A AA A
A T A T T T T
TATA box Start point Template
DNA strand
5′
3′
3′
5′
Transcription
factors
5′
3′
3′
5′
Promoter
5′
3′
3′
5′5′
RNA polymerase II
Transcription factors
RNA transcript
Transcription initiation complex
Eukaryotic promoters1
Several transcription
factors
2
Additional transcription
factors
3
Synthesis of an RNA Transcript - Initiation
9. Synthesis of an RNA Transcript - Elongation
RNA polymerase synthesizes a single strand of RNA against the DNA
template strand (anti-sense strand), adding nucleotides to the 3’ end of
the RNA chain.
As RNA polymerase moves along the DNA it continues to untwist the
double helix, exposing about 10 to 20 DNA bases at a time for pairing
with RNA nucleotides.
Elongation
RNA
polymerase
Non-template
strand of DNA
RNA nucleotides
3′ end
C A E G C A A
U
T A G G T T
A
A
C
G
U
A
T
C
A
T C C A A T
T
G
G
3′
5′
5′
Newly made
RNA
Direction of transcription
(“downstream”) Template
strand of DNA
10. Specific sequences in the DNA signal termination of transcription.
When one of these is encountered by the polymerase, the RNA
transcript is released from the DNA and the double helix can zip
up again.
Synthesis of an RNA Transcript -
Termination
11. Most eukaryotic mRNAs aren’t ready to be translated into protein
directly after being transcribed from DNA. mRNA requires
processing.
Transcription of RNA processing occur in the nucleus. After this,
the messenger RNA moves to the cytoplasm for translation.
The cell adds a protective cap to one end, and a tail of A’s to the
other end. These both function to protect the RNA from enzymes
that would degrade it.
Most of the genome consists of non-coding regions called
introns.
Non-coding regions may have specific chromosomal functions or
have regulatory purposes.
Introns also allow for alternative RNA splicing.
Thus, an RNA copy of a gene is converted into messenger RNA
by doing 2 things:
1. Add protective bases to the ends.
2. Cut out the introns.
Post Termination RNA Processing
12. Alteration of mRNA
Ends
Each end of a pre-mRNA molecule is modified in a particular way:
The 5′ end receives a modified nucleotide cap.
The 3′ end gets a poly-A tail.
A modified guanine nucleotide
added to the 5′ end
50 to 250 adenine nucleotides
added to the 3′ end
Protein-coding segment Polyadenylation signal
Poly-A tail3′ UTR
Stop codonStart codon
5′ Cap 5′ UTR
AAUAAA AAA…AAA
TRANSCRIPTION
RNA PROCESSING
DNA
Pre-mRNA
mRNA
TRANSLATION
Ribosome
Polypeptide
G P P P
5′
3′
13. RNA Processing -
Splicing
The original transcript from the
DNA is called pre-mRNA.
It contains transcripts of both
introns and exons.
The introns are removed by a
process called splicing to
produce messenger RNA
(mRNA).
Ribozymes are catalytic RNA
molecules that function as
enzymes and can splice RNA.
RNA splicing removes introns
and joins exons.
14. TRANSCRIPTION
RNA PROCESSING
DNA
Pre-mRNA
mRNA
TRANSLATION
Ribosome
Polypeptide
5′ Cap
Exon Intron
1
5′
30 31
Exon Intron
104 105 146
Exon 3′
Poly-A tail
Poly-A tail
Introns cut out and
exons spliced together
Coding
segment
5′ Cap
1 146
3′ UTR3′ UTR
Pre-mRNA
mRNA
RNA Splicing can
also be carried out
by spliceosomes.
RNA transcript (pre-mRNA)
Exon 1 Intron Exon 2
Other proteins
Protein
snRNA
snRNPs
Spliceosome
Spliceosome
components
Cut-out
intronmRNA
Exon 1 Exon 2
5′
5′
5′
1
2
3
15. Alternative Splicing (of
Exons)
How is it possible that there are millions of human antibodies
when there are only about 30,000 genes?
Alternative splicing refers to the different ways the exons of a
gene may be combined, producing different forms of proteins
within the same gene-coding region.
Alternative pre-mRNA splicing is an important mechanism for
regulating gene expression in higher eukaryotes.
RNA
Processing
Proteins often have a modular
architecture consisting of
discrete structural and
functional regions called
domains.
In many cases different exons
code for the different domains
in a protein.
Gene
DNA
Exon 1 Intron Exon 2 Intron Exon 3
Transcription
RNA processing
Translation
Domain 3
Domain 1
Domain 2
Polypeptide
16. Translation:
Translation istheRNA-
directed synthesisof a
polypeptide.
Translation involves:
1. mRNA
2. Ribosomes- Ribosomal
RNA
3. Transfer RNA
4. Genetic coding - codons
TRANSCRIPTION
TRANSLATION
DNA
mRNA
Ribosome
Polypeptide
Polypeptide
Amino
acids
tRNA with
amino acid
attached
Ribosome
tRNA
Anticodon
mRNA
Trp
Phe Gly
A
G
C
A A A
C
C
G
U G G U U U G G C
Codons5′ 3′
17. TheGenetic
Code
Genetic information
isencoded asa
sequenceof non-
overlapping base
triplets, or codons.
Thegenedetermines
thesequenceof
basesalong the
length of an mRNA
molecule.
DNA
molecule
Gene 1
Gene 2
Gene 3
DNA strand
(template)
TRANSCRIPTION
mRNA
Protein
TRANSLATION
Amino acid
A C C A A A C C G A G T
U G G U U U G G C U C A
Trp Phe Gly Ser
Codon
3′ 5′
3′5′
18. TheGenetic Code:
Codons: 3 basecodefor theproduction of aspecific amino
acid, sequenceof threeof thefour different nucleotides.
Sincethereare4 basesand 3 positionsin each codon, thereare
4 x 4 x 4 = 64 possiblecodons.
64 codonsbut only 20 amino acids, thereforemost havemore
than 1 codon
3 of the64 codonsareused asSTOPsignals; they arefound at
theend of every geneand mark theend of theprotein.
Onecodon isused asaSTART signal: it isat thestart of every
protein.
Universal: in all living organisms.
A codon in messenger RNA iseither translated into an amino
acid or servesasatranslational start/stop signal.
19. Second mRNA base
U C A G
U
C
A
G
UUU
UUC
UUA
UUG
CUU
CUC
CUA
CUG
AUU
AUC
AUA
AUG
GUU
GUC
GUA
GUG
Met or
start
Phe
Leu
Leu
lle
Val
UCU
UCC
UCA
UCG
CCU
CCC
CCA
CCG
ACU
ACC
ACA
ACG
GCU
GCC
GCA
GCG
Ser
Pro
Thr
Ala
UAU
UAC
UGU
UGC
Tyr Cys
CAU
CAC
CAA
CAG
CGU
CGC
CGA
CGG
AAU
AAC
AAA
AAG
AGU
AGC
AGA
AGG
GAU
GAC
GAA
GAG
GGU
GGC
GGA
GGG
UGG
UAA
UAG Stop
Stop UGA Stop
Trp
His
Gln
Asn
Lys
Asp
Arg
Ser
Arg
Gly
U
C
A
G
U
C
A
G
U
C
A
G
U
C
A
G
FirstmRNAbase(5′end)
ThirdmRNAbase(3′end)
Glu
20. TransferRNA:
Consistsof asingleRNA strand that isonly about 80
nucleotideslong. Each carriesaspecific amino acid on one
end and hasan anticodon on theother end.
A special group of enzymespairsup theproper tRNA
moleculeswith their corresponding amino acids.
tRNA bringstheamino acidsto theribosomes.
Two-dimensional structure. The four base-
paired regions and three loops are
characteristic of all tRNAs, as is the base
sequence of the amino acid attachment site at
the 3′ end. The anticodon triplet is unique to
each tRNA type. (The asterisks mark bases that
have been chemically modified, a characteristic
of tRNA.)
3′
C
C
A
C
G
C
U
U
A
A
GACACCU
*
G
C
* *
G U G U
*CU
* G AG
G
U
*
*A
*
A
A G
U
C
A
G
A
C
C
*
C G A G
A G G
G
*
*
GA
CUC*AU
U
U
A
G
G
C
G
5′
Amino acid
attachment site
Hydrogen
bonds
Anticodon
A
The “anticodon” is the 3 RNA bases that
matches the 3 bases of the codon on the
mRNA molecule
21. 3 dimensional tRNA
moleculeisroughly
“L” shape.
(b) Three-dimensional structure
Symbol used
in the book
Amino acid
attachment site
Hydrogen
bonds
Anticodon
Anticodon
A A G
5′
3′
3′ 5′
(c)
Ribosomes:
Ribosomesfacilitatethe
specific coupling of tRNA
anticodonswith mRNA
codonsduring protein
synthesis.
The2 ribosomal subunitsare
constructed of proteinsand
RNA moleculesnamed
ribosomal RNA or rRNA
22. Theribosomehasthreebinding sitesfor tRNA:
ThePsite TheA site TheE site
E P A
P site (Peptidyl-tRNA
binding site)
E site
(Exit site)
mRNA
binding site
A site (Aminoacyl-
tRNA binding site)
Large
subunit
Small
subunit
Schematic model showing binding sites. A
ribosome has an mRNA binding site and three tRNA
binding sites, known as the A, P, and E sites. This
schematic ribosome will appear in later diagrams.
Amino end Growing polypeptide
Next amino acid
to be added to
polypeptide chain
tRNA
mRNA
Codons
3′
5′
Schematic model with mRNA and tRNA. A tRNA fits into a binding
site when its anticodon base-pairs with an mRNA codon. The P site
holds the tRNA attached to the growing polypeptide. The A site holds
the tRNA carrying the next amino acid to be added to the polypeptide
chain. Discharged tRNA leaves via the E site.
23. BuildingaMoleculeof
tRNA:
A specific enzymecalled an
aminoacyl-tRNA synthetase
joinseach amino acid to the
correct tRNA.
Amino acid
ATP
Adenosine
Pyrophosphate
Adenosine
Adenosine
Phosphates
tRNA
P P P
P
P Pi
Pi
Pi
P
AMP
Aminoacyl tRNA
(an “activated
amino acid”)
Aminoacyl-tRNA
synthetase (enzyme)
Active site binds the
amino acid and ATP.
1
ATP loses two P groups
and joins amino acid as AMP.
2
3 Appropriate
tRNA covalently
Bonds to amino
Acid, displacing
AMP.
Activated amino acid
is released by the enzyme.
4
BuildingaPolypeptide
Wecan dividetranslation into three
stages:
1. Initiation 2.
Elongation 3. Termination
TheAUG start codon isrecognized by methionyl-tRNA or Met.
Oncethestart codon hasbeen identified, theribosomeincorporates
amino acidsinto apolypeptidechain.
RNA isdecoded by tRNA (transfer RNA) molecules, which each
transport specific amino acidsto thegrowing chain.
Translation endswhen astop codon (UAA, UAG, UGA) isreached.
24. Initiationof Translation:
Theinitiation stageof translation bringstogether mRNA,
tRNA bearing thefirst amino acid of thepolypeptide, and two
subunitsof aribosome Large
ribosomal
subunit
The arrival of a large ribosomal subunit completes
the initiation complex. Proteins called initiation
factors (not shown) are required to bring all the
translation components together. GTP provides
the energy for the assembly. The initiator tRNA is
in the P site; the A site is available to the tRNA
bearing the next amino acid.
2
Initiator tRNA
mRNA
mRNA binding site Small
ribosomal
subunit
Translation initiation complex
P site
GDPGTP
Start codon
A small ribosomal subunit binds to a molecule of
mRNA. In a prokaryotic cell, the mRNA binding site
on this subunit recognizes a specific nucleotide
sequence on the mRNA just upstream of the start
codon. An initiator tRNA, with the anticodon UAC,
base-pairs with the start codon, AUG. This tRNA
carries the amino acid methionine (Met).
1
Met
Met
U A C
A U G
E A
3′
5′
5′
3′
3′5′ 3′5′
25. Elongationof thePolypeptideChain:
In theelongation stage, amino acidsareadded oneby oneto
thepreceding amino acid.
Amino end
of polypeptide
mRNA
Ribosome ready for
next aminoacyl tRNA
E
P A
E
P A
E
P A
E
P A
GDP
GTP
GTP
GDP
2
2
site site5′
3′
TRANSCRIPTION
TRANSLATION
DNA
mRNA
Ribosome
Polypeptide
Codon recognition. The anticodon
of an incoming aminoacyl tRNA
base-pairs with the complementary
mRNA codon in the A site. Hydrolysis
of GTP increases the accuracy and
efficiency of this step.
1
Peptide bond formation. An
rRNA molecule of the large
subunit catalyzes the formation
of a peptide bond between the
new amino acid in the A site and
the carboxyl end of the growing
polypeptide in the P site.
This step attaches the
polypeptide to the tRNA in the A
2
Translocation. The ribosome
translocates the tRNA in the A
site to the P site. The empty tRNA
in the P site is moved to the E site,
where it is released. The mRNA
moves along with its bound tRNAs,
bringing the next codon to be
translated into the A site.
3
26. Terminationof Translation:
Thefinal step in translation istermination. When theribosome
reachesaSTOPcodon, thereisno corresponding transfer RNA.
Instead, asmall protein called a“releasefactor” attachesto thestop
codon. Thereleasefactor causesthewholecomplex to fall apart:
messenger RNA, thetwo ribosomesubunits, thenew polypeptide.
Themessenger RNA can betranslated many times, to producemany
protein copies.
Release
factor
Free
polypeptide
Stop codon
(UAG, UAA, or UGA)
5′
3′ 3′
5′
3′
5′
When a ribosome reaches a stop
codon on mRNA, the A site of the
ribosome accepts a protein called
a release factor instead of tRNA.
1
The release factor hydrolyzes
the bond between the tRNA in
the P site and the last amino
acid of the polypeptide chain.
The polypeptide is thus freed
from the ribosome.
2
3 The two ribosomal subunits
and the other components of
the assembly dissociate.
27. Translation: Initiation
mRNA bindsto aribosome, and thetransfer RNA corresponding to the
START codon bindsto thiscomplex. Ribosomesarecomposed of 2
subunits(largeand small), which cometogether when themessenger
RNA attachesduring theinitiation process.
Translation: Elongation
Elongation: theribosomemovesdown themessenger RNA, adding new
amino acidsto thegrowing polypeptidechain. Theribosomehas2 sites
for binding transfer RNA. Thefirst RNA with itsattached amino acid
bindsto thefirst site, and then thetransfer RNA corresponding to the
second codon bind to thesecond site. Theribosomethen removesthe
amino acid from thefirst transfer RNA and attachesit to thesecond
amino acid. At thispoint, thefirst transfer RNA isempty: no attached
amino acid, and thesecond transfer RNA hasachain of 2 amino acids
attached to it.
Translation: Termination
Theelongation cyclerepeatsastheribosomemovesdown themessenger
RNA, translating it onecodon and oneamino acid at atime.
28. Polyribosomes:
A number of ribosomes
can translateasingle
mRNA molecule
simultaneously forming a
polyribosome
Polyribosomesenablea
cell to makemany copies
of apolypeptidevery
quickly.
Growing
polypeptides
Completed
polypeptide
Incoming
ribosomal
subunits
Start of
mRNA
(5′ end)
End of
mRNA
(3′ end)
Polyribosome
An mRNA molecule is generally translated simultaneously
by several ribosomes in clusters called polyribosomes.
(a)
Ribosomes
mRNA
This micrograph shows a large polyribosome in a prokaryotic
cell (TEM).
0.1 µm
Theprocessrepeatsuntil aSTOP
codon isreached.
29. Inaeukaryotic cell:
Thenuclear envelopeseparatestranscription from translation.
ExtensiveRNA processing occursin thenucleus.
Prokaryotic cellslack anuclear envelope, allowing translation
to begin whiletranscription progresses.
RNA polymerase
DNA
Polyribosome
RNA
polymerase
Direction of
transcription
mRNA
0.25 µm
DNA
Polyribosome
Polypeptide
(amino end)
Ribosome
mRNA (5′ end)
30. Figure 17.26
TRANSCRIPTION
RNA is transcribed
from a DNA template.
DNA
RNA
polymerase
RNA
transcript
RNA PROCESSING
In eukaryotes, the
RNA transcript (pre-
mRNA) is spliced and
modified to produce
mRNA, which moves
from the nucleus to the
cytoplasm.
Exon
Poly-A
RNA transcript
(pre-mRNA)
Intron
NUCLEUS
Cap
FORMATION OF
INITIATION COMPLEX
After leaving the
nucleus, mRNA attaches
to the ribosome.
CYTOPLASM
mRNA
Poly-A
Growing
polypeptide
Ribosomal
subunits
Cap
Aminoacyl-tRNA
synthetase
Amino
acid
tRNA
AMINO ACID ACTIVATION
Each amino acid
attaches to its proper tRNA
with the help of a specific
enzyme and ATP.
Activated
amino acid
TRANSLATION
A succession of tRNAs
add their amino acids to
the polypeptide chain
as the mRNA is moved
through the ribosome
one codon at a time.
(When completed, the
polypeptide is released
from the ribosome.)
Anticodon
A
C
C
A A A
U G G U U U A U G
U
A CE A
Ribosome
1
Poly-A
5′
5′
3′
Codon
2
3 4
5
31. Post-translation:
Thenew polypeptideisnow floating loosein thecytoplasm if
translated by afreeribosome. Polypeptidesfold spontaneously into
their activeconfiguration, and they spontaneously join with other
polypeptidesto form thefinal proteins. Often translation isnot
sufficient to makeafunctional protein, polypeptidechainsare
modified after translation. Sometimesother moleculesarealso
attached to thepolypeptides: sugars, lipids, phosphates, etc. All of
thesehavespecial purposesfor protein function.
TargetingPolypeptides toSpecific Locations:
Completed proteinsaretargeted to specific sitesin thecell. Two
populationsof ribosomesareevident in cells: freeribsomes(in the
cytosol) and bound ribosomes(attached to theER). Freeribosomes
mostly synthesizeproteinsthat function in thecytosol. Bound
ribosomesmakeproteinsof theendomembranesystem and proteins
that aresecreted from thecell. Ribosomesareidentical and can switch
from freeto bound
32. Polypeptidesynthesisalwaysbeginsin thecytosol. Synthesisfinishes
in thecytosol unless thepolypeptidesignalstheribosometo attach to
theER. Polypeptidesdestined for theER or for secretion aremarked
by asignal peptide. A signal-recognition particle(SRP) bindsto the
signal peptide. TheSRPbringsthesignal peptideand itsribosometo
theER.
Ribosomes
mRNA
Signal
peptide
Signal-
recognition
particle
(SRP)
SRP
receptor
protein
CYTOSOL
ER LUMEN Translocation
complex
Signal
peptide
removed
ER
membrane
Protein